{"id":35983,"date":"2025-10-20T09:13:30","date_gmt":"2025-10-20T07:13:30","guid":{"rendered":"https:\/\/ggba.swiss\/?p=35983"},"modified":"2025-10-20T09:14:52","modified_gmt":"2025-10-20T07:14:52","slug":"essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/","title":{"rendered":"EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation"},"content":{"rendered":"\n<p>Global vision care leader <a href=\"https:\/\/www.essilorluxottica.com\/en\/\">EssilorLuxottica<\/a> has acquired Ikerian AG, the Bern-based health technology company operating under the <a href=\"https:\/\/www.retinai.com\/\">RetinAI<\/a> brand. The acquisition marks a key milestone in the Group\u2019s medtech strategy, expanding its portfolio with advanced machine learning and data analytics tools that enhance clinical, research, and pharmaceutical workflows.<\/p>\n\n\n\n<p>Founded in 2017, RetinAI develops AI-powered software platforms that collect, process, and analyze large-scale retinal images and biomarker datasets. Its FDA-cleared and CE-marked RetinAI Discovery\u00ae platform supports clinicians in diagnosing and monitoring eye diseases such as age-related macular degeneration (AMD), diabetic retinopathy, and glaucoma. By transforming medical images into actionable insights, RetinAI\u2019s technology enables faster, more accurate decisions in patient care.<\/p>\n\n\n\n<p>The company also collaborates with leading pharmaceutical partners to leverage real-world evidence data, accelerating clinical studies and supporting drug development. These capabilities align closely with EssilorLuxottica\u2019s goal of creating a fully integrated, data-driven ecosystem for vision care.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">More accurate diagnoses and effective disease monitoring<\/h4>\n\n\n\n<p>\u201cIn the past year alone, we\u2019ve made several bold moves in med-tech, all with the goal of building the most comprehensive, digitally enabled patient journey,\u201d said Francesco Milleri, Chairman and CEO of EssilorLuxottica. \u201cLeveraging RetinAI\u2019s AI-powered analytics, we can turn clinical data into insights that enable faster, more accurate diagnoses and more effective disease monitoring.\u201d<\/p>\n\n\n\n<p>For Carlos Ciller, PhD, Chairman and CEO of RetinAI and Ikerian, the acquisition represents a transformative opportunity: \u201cJoining EssilorLuxottica marks a defining moment in our journey. With its global reach and commitment to innovation, we can now bring our vision for data-driven patient care to life on a new scale.\u201d<\/p>\n\n\n\n<p>This acquisition marks the culmination of a <a href=\"https:\/\/ggba.swiss\/en\/ikerian-secures-usd-8-million-and-a-strategic-partnership-with-sanoptis\/\">rapid growth trajectory for RetinAI<\/a> and its parent company Ikerian, which previously <a href=\"https:\/\/ggba.swiss\/en\/ikerian-parent-company-of-retinai-secures-usd-6-18-million-for-ai-driven-medical-advancements\/\">secured USD 6.18 million in Series A funding to expand their AI-driven platforms and data capabilities<\/a>.<\/p>\n\n\n\n<p>From its beginnings in Bern as a spin-off focused on ophthalmic imaging, to becoming a recognized partner for pharmaceutical and clinical research worldwide, the company\u2019s evolution exemplifies Western Switzerland\u2019s growing strength in digital health and medical AI innovation.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>EssilorLuxottica\u2019s acquisition of RetinAI strengthens its medtech portfolio with advanced AI and data-driven solutions for eye disease management.<\/p>\n","protected":false},"author":6,"featured_media":35984,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[833],"tags":[893,930,890,918,887],"class_list":["post-35983","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-life-science","tag-artificial-intelligence","tag-digital-health","tag-healthcare","tag-investment","tag-software"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EssilorLuxottica acquires Bern-based RetinAI | GGBa<\/title>\n<meta name=\"description\" content=\"EssilorLuxottica\u2019s acquisition of RetinAI strengthens its portfolio with advanced AI and data-driven solutions for eye disease management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EssilorLuxottica acquires Bern-based RetinAI | GGBa\" \/>\n<meta property=\"og:description\" content=\"EssilorLuxottica\u2019s acquisition of RetinAI strengthens its portfolio with advanced AI and data-driven solutions for eye disease management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-20T07:13:30+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-20T07:14:52+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation\",\"datePublished\":\"2025-10-20T07:13:30+00:00\",\"dateModified\":\"2025-10-20T07:14:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\"},\"wordCount\":346,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg\",\"keywords\":[\"Artificial Intelligence\",\"Digital Health\",\"Healthcare\",\"Investment\",\"Software\"],\"articleSection\":[\"Life sciences\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\",\"url\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\",\"name\":\"EssilorLuxottica acquires Bern-based RetinAI | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg\",\"datePublished\":\"2025-10-20T07:13:30+00:00\",\"dateModified\":\"2025-10-20T07:14:52+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"EssilorLuxottica\u2019s acquisition of RetinAI strengthens its portfolio with advanced AI and data-driven solutions for eye disease management.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"RetinAI\u2019s Bern-based team develops AI-powered software to support early diagnosis and disease monitoring in ophthalmology. | \u00a9 RetinAI\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EssilorLuxottica acquires Bern-based RetinAI | GGBa","description":"EssilorLuxottica\u2019s acquisition of RetinAI strengthens its portfolio with advanced AI and data-driven solutions for eye disease management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/","og_locale":"en_US","og_type":"article","og_title":"EssilorLuxottica acquires Bern-based RetinAI | GGBa","og_description":"EssilorLuxottica\u2019s acquisition of RetinAI strengthens its portfolio with advanced AI and data-driven solutions for eye disease management.","og_url":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-10-20T07:13:30+00:00","article_modified_time":"2025-10-20T07:14:52+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Pierre-Yves Oehrli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation","datePublished":"2025-10-20T07:13:30+00:00","dateModified":"2025-10-20T07:14:52+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/"},"wordCount":346,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg","keywords":["Artificial Intelligence","Digital Health","Healthcare","Investment","Software"],"articleSection":["Life sciences"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/","url":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/","name":"EssilorLuxottica acquires Bern-based RetinAI | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg","datePublished":"2025-10-20T07:13:30+00:00","dateModified":"2025-10-20T07:14:52+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"EssilorLuxottica\u2019s acquisition of RetinAI strengthens its portfolio with advanced AI and data-driven solutions for eye disease management.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/10\/RetinAI-Founders-1180x811-1.jpg","width":2560,"height":1707,"caption":"RetinAI\u2019s Bern-based team develops AI-powered software to support early diagnosis and disease monitoring in ophthalmology. | \u00a9 RetinAI"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/en\/essilorluxottica-acquires-bern-based-retinai-to-accelerate-ai-powered-eye-health-innovation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/en\/"},{"@type":"ListItem","position":2,"name":"EssilorLuxottica acquires Bern-based RetinAI to accelerate AI-powered eye health innovation"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/en\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35983","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/comments?post=35983"}],"version-history":[{"count":3,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35983\/revisions"}],"predecessor-version":[{"id":35989,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/posts\/35983\/revisions\/35989"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media\/35984"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/media?parent=35983"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/categories?post=35983"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/en\/wp-json\/wp\/v2\/tags?post=35983"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}